Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information?

Abstract Breast cancer (BC) has historically been treated as a single disease entity; however, in the last decade, insights into its molecular heterogeneity have underpinned the development/commercialisation of several genomic tools whose goal is to guide patient management in early BC. These includ...

Ausführliche Beschreibung